ST Cytonome Overview
- Year Founded
-
2002
- Status
-
Private
- Employees
-
67
- Latest Deal Type
-
2ndary - Private
- Investors
-
1
ST Cytonome General Information
Description
Developer of clinical-grade optical cell sorting systems designed to offer application-specific technology for cell therapy, life science, and industrial markets. The company's systems develop and offer cell purification and cell sorting devices for the separation of human donor cells for bone marrow transplantation, treatment of autoimmune diseases, and heart failure, enabling researchers to develop products that simplify existing workflows for leading-edge advances and research.
Contact Information
Website
www.cytonome.comCorporate Office
- 9 Oak Park Drive
- Bedford, MA 01730
- United States
Corporate Office
- 9 Oak Park Drive
- Bedford, MA 01730
- United States
ST Cytonome Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Secondary Transaction - Private | 01-Nov-2022 | Completed | Generating Revenue | |||
| 3. Grant | 11-Jun-2013 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series B) | 20-Jan-2005 | $6.89M | $8.24M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A2) | 19-Aug-2002 | $1.35M | $1.35M | Completed | Startup |
ST Cytonome Comparisons
Industry
Financing
Details
ST Cytonome Competitors (20)
One of ST Cytonome’s 20 competitors is Illumina, a Formerly VC-backed company based in San Diego, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Illumina | Formerly VC-backed | San Diego, CA | ||||
| Sphere Fluidics | Formerly VC-backed | Cambridge, United Kingdom | ||||
| Agena Bioscience | Formerly PE-Backed | San Diego, CA | ||||
| DNAe | Formerly VC-backed | London, United Kingdom | ||||
| Oxford Nanopore Technologies | Formerly VC-backed | Oxford, United Kingdom |
ST Cytonome Patents
ST Cytonome Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260097421-A1 | Probability sorter | Pending | 03-Jul-2024 | ||
| WO-2026011151-A1 | Probability sorter | Pending | 03-Jul-2024 | ||
| AU-2023367015-A1 | Segmented side fluorescence detector flow cytometry | Pending | 28-Oct-2022 | ||
| EP-4609171-A1 | Segmented side fluorescence detector flow cytometry | Pending | 28-Oct-2022 | ||
| US-12699037-B2 | Segmented side fluorescence detector flow cytometry | Active | 28-Oct-2022 | G01N15/1434 |
ST Cytonome Signals
ST Cytonome Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Massachusetts Technology Collaborative | Accelerator/Incubator |
ST Cytonome FAQs
-
When was ST Cytonome founded?
ST Cytonome was founded in 2002.
-
Where is ST Cytonome headquartered?
ST Cytonome is headquartered in Bedford, MA.
-
What is the size of ST Cytonome?
ST Cytonome has 67 total employees.
-
What industry is ST Cytonome in?
ST Cytonome’s primary industry is Other Devices and Supplies.
-
Is ST Cytonome a private or public company?
ST Cytonome is a Private company.
-
What is ST Cytonome’s current revenue?
The current revenue for ST Cytonome is .
-
How much funding has ST Cytonome raised over time?
ST Cytonome has raised $8.24M.
-
Who are ST Cytonome’s investors?
Massachusetts Technology Collaborative has invested in ST Cytonome.
-
Who are ST Cytonome’s competitors?
Illumina, Sphere Fluidics, Agena Bioscience, DNAe, and Oxford Nanopore Technologies are some of the 20 competitors of ST Cytonome.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process